-
公开(公告)号:US20120178739A1
公开(公告)日:2012-07-12
申请号:US13419663
申请日:2012-03-14
申请人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
发明人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
CPC分类号: C07D491/14 , C07D471/14 , C07D487/04 , C07D495/14
摘要: The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
摘要翻译: 本发明提供了可用作蛋白激酶抑制剂的新化合物。 本发明还提供包含本发明化合物的药物组合物和使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US20110039820A1
公开(公告)日:2011-02-17
申请号:US12903370
申请日:2010-10-13
申请人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
发明人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
CPC分类号: C07D491/14 , C07D471/14 , C07D487/04 , C07D495/14
摘要: The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
摘要翻译: 本发明提供了可用作蛋白激酶抑制剂的新化合物。 本发明还提供包含本发明化合物的药物组合物和使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US07459448B2
公开(公告)日:2008-12-02
申请号:US11242413
申请日:2005-10-03
申请人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
发明人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
IPC分类号: C07D487/04 , A61K31/55
CPC分类号: C07D491/14 , C07D471/14 , C07D487/04 , C07D495/14
摘要: The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
摘要翻译: 本发明提供了可用作蛋白激酶抑制剂的新化合物。 本发明还提供包含本发明化合物的药物组合物和使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US20070293498A1
公开(公告)日:2007-12-20
申请号:US11878708
申请日:2007-07-26
IPC分类号: A61K31/40 , A61K31/166 , A61K31/4025 , A61K31/495 , A61P19/08 , A61P3/04 , C07D207/09 , C07D233/64 , C07D239/70 , C07D413/06 , C07D409/12 , C07D401/06 , C07D333/38 , C07D295/145 , C07D239/14 , C07D233/48 , C07C235/42 , A61P25/00 , A61K31/5375 , A61K31/4164 , A61K31/381
CPC分类号: C07C279/22 , C07C317/32 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/10 , C07D207/12 , C07D207/14 , C07D207/16 , C07D207/22 , C07D209/14 , C07D211/26 , C07D211/34 , C07D211/60 , C07D211/62 , C07D213/40 , C07D217/02 , C07D231/12 , C07D233/56 , C07D233/88 , C07D239/16 , C07D239/42 , C07D249/08 , C07D295/13 , C07D295/185 , C07D307/79 , C07D333/20 , C07D333/38 , C07D401/06 , C07D407/12 , C07D409/12 , C07D451/04 , C07D453/02 , C07D471/10
摘要: This invention provides compounds and methods for treating melanocortin receptor associated disorders, such as weight loss disorders including cachexia resulting from cancer and other chronic illnesses. The compounds are represented by formula I: wherein X is oxygen or sulfur; G is G1 or G2: L1, L2, L3 and Q are linker groups, and Rings A, B and C, and R1-R14 are described in the specification. The compounds are antagonists of melanocortin receptors.
摘要翻译: 本发明提供了用于治疗黑皮质素受体相关疾病的化合物和方法,例如包括由癌症和其它慢性疾病引起的恶病质的体重减轻障碍。 化合物由式I表示:其中X是氧或硫; G是G1或G2:L 1,L 2,L 3和Q是连接基,环A,B和C和 在说明书中描述了R 1〜R 14。 这些化合物是黑皮质素受体的拮抗剂。
-
公开(公告)号:US20120053201A1
公开(公告)日:2012-03-01
申请号:US13217401
申请日:2011-08-25
申请人: Christopher Blackburn , Kenneth M. Gigstad , He Xu
发明人: Christopher Blackburn , Kenneth M. Gigstad , He Xu
IPC分类号: A61K31/4375 , A61P35/00 , A61P35/02 , C07D471/04
CPC分类号: C07D471/04 , A61K31/4375 , C07D215/54
摘要: This invention provides compounds of formula (I): wherein R1a, R1b, R1c, R1d, R2a, R2b, X1, X2, and G have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.
摘要翻译: 本发明提供式(I)化合物:其中R1a,R1b,R1c,R1d,R2a,R2b,X1,X2和G具有如本说明书中所述的值,可用作HDAC6的抑制剂。 本发明还提供包含本发明化合物的药物组合物和使用该组合物治疗增殖性,炎症性,感染性,神经性或心血管疾病或病症的方法。
-
公开(公告)号:US20120015943A1
公开(公告)日:2012-01-19
申请号:US13184600
申请日:2011-07-18
申请人: Christopher Blackburn , Emily F. Calderwood , Kenneth M. Gigstad , Alexandra E. Gould , Sean J. Harrison , He Xu
发明人: Christopher Blackburn , Emily F. Calderwood , Kenneth M. Gigstad , Alexandra E. Gould , Sean J. Harrison , He Xu
IPC分类号: A61K31/166 , A61K31/4545 , C07C259/10 , C07D239/42 , A61K31/505 , C07D213/75 , A61K31/4418 , C07D213/68 , A61K31/4409 , C07D211/62 , A61K31/4465 , C07D207/34 , A61K31/40 , C07D487/08 , A61K31/407 , A61P35/00 , C07D413/06 , A61K31/5377 , C07D401/12
CPC分类号: C07D239/26 , A61K31/166 , A61K31/40 , A61K31/407 , A61K31/4409 , A61K31/4418 , A61K31/4465 , A61K31/4545 , A61K31/505 , A61K31/5377 , C07C259/10 , C07C259/18 , C07C271/58 , C07C275/28 , C07C311/20 , C07C2601/14 , C07C2602/10 , C07C2602/42 , C07C2603/74 , C07D207/34 , C07D209/42 , C07D211/62 , C07D211/64 , C07D213/40 , C07D213/56 , C07D213/68 , C07D213/75 , C07D213/81 , C07D231/12 , C07D231/14 , C07D261/18 , C07D277/62 , C07D307/68 , C07D307/85 , C07D333/70 , C07D409/06 , C07D471/04
摘要: This invention provides compounds of formula (I): wherein R1, R1b, R2a, R2b, R2c, and R2d have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.
摘要翻译: 本发明提供式(I)化合物:其中R1,R1b,R2a,R2b,R2c和R2d具有如本说明书中所述的值,可用作HDAC6的抑制剂。 本发明还提供包含本发明化合物的药物组合物和使用该组合物治疗增殖性,炎症性,感染性,神经性或心血管疾病或病症的方法。
-
公开(公告)号:US07935694B2
公开(公告)日:2011-05-03
申请号:US12231661
申请日:2008-09-04
申请人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
发明人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
IPC分类号: A61P35/00
CPC分类号: C07D491/14 , C07D471/14 , C07D487/04 , C07D495/14
摘要: The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
摘要翻译: 本发明提供了可用作蛋白激酶抑制剂的新化合物。 本发明还提供包含本发明化合物的药物组合物和使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US20090105213A1
公开(公告)日:2009-04-23
申请号:US12231661
申请日:2008-09-04
申请人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
发明人: Christopher Blackburn , Christopher F. Claiborne , Courtney A. Cullis , Natalie A. Dales , Michael Patane , Matthew Stirling , Omar Stradella , Gabriel S. Weatherhead
IPC分类号: A61K31/55 , A61K31/397 , A61P35/00
CPC分类号: C07D491/14 , C07D471/14 , C07D487/04 , C07D495/14
摘要: The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
摘要翻译: 本发明提供了可用作蛋白激酶抑制剂的新化合物。 本发明还提供包含本发明化合物的药物组合物和使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US4838659A
公开(公告)日:1989-06-13
申请号:US124100
申请日:1987-12-10
申请人: Robert L. Van Ewyk , Ingrid M. O'Connor , Alan Mosley , Francis Jones , Christopher Blackburn , John Griffiths
发明人: Robert L. Van Ewyk , Ingrid M. O'Connor , Alan Mosley , Francis Jones , Christopher Blackburn , John Griffiths
CPC分类号: G02F1/13762 , C09B3/14 , C09K19/60 , C09K19/606 , Y10T428/1041
摘要: Pleochroic fluorescent dyes of the general formula I: ##STR1## in which R is hydrogen or an aliphatic hydrocarbon radical containing not more than 20 carbon atoms and --CH.sub.2 -- between carbon atoms or adjacent to the bicyclo[2.2]octane residue may be replaced by --O-- may be dissolved in liquid crystal host material to form displays which are caused to fluoresce by incident low-energy ultraviolet initially absorbed by the liquid cyrstal host material and then internally transferred to the fluorophor. These dyes have greater stability to ultraviolet than other perylenedicarboxylic diesters while possessing good fluorescent properties and satisfactory order parameters. In formula I, R is preferably a straight or branched alkyl, and/or cycloalkyl group having 3 to 10 carbon atoms, preferably 5 to 7 carbon atoms. The liquid cyrstal host material preferably contains an energy-transfer agent such as a 4-substituted 4"-cyanoterphenyl. The 4-pentyl- and 4-propyl- bicyclo[2.2.2]oct-1-yl perylenedicarboxylates of Formula I and solutions of these dyes in nematic liquid crystal host "E7" (a mixture based on cyanobiphenyls containing 8% 4-pentyl-4"-cyanoterphenyl) are described in examples.
摘要翻译: PCT No.PCT / GB87 / 00196 Sec。 371日期1987年12月10日 102(e)1987年12月10日日,1987年3月20日PCT PCT。 公开号WO87 / 05617 日本公报1987年9月24日。通式I的双色荧光染料:其中R是氢或含有不超过20个碳原子的脂族烃基和碳原子之间的-CH 2 - 或邻近 双环[2.2]辛烷残基可以被-O-取代,可以溶解在液晶主体材料中,形成显示器,这些显示器最初被液态硅藻土主体材料吸收的入射低能量紫外线发出荧光,然后内部转移到荧光体 。 这些染料具有比其它苝二羧酸二酯更高的紫外线稳定性,同时具有良好的荧光性能和令人满意的顺序参数。 在式I中,R优选为具有3至10个碳原子,优选5至7个碳原子的直链或支链烷基和/或环烷基。 液体硅藻土主体材料优选含有能量转移剂,例如4-取代的4“ - 氰基苯基。 式I的4-戊基 - 和4-丙基 - 双环[2.2.2]辛-1-基辛基-1-基和这些染料在向列型液晶宿主“E7”中的溶液(基于含有8%4-戊基的氰基联苯 -4“ - 氰基苯基)在实施例中描述。
-
-
-
-
-
-
-
-